While hair loss is not established as a class effect of GLP-1 medications, clinical trial data and product information vary by agent
At time 0, a bolus of glucose (2 g/kg, 10 ml/kg, Fresenius Kabi, Uppsala, Sweden) was administered by oral gavage
Some patients report sustained appetite reduction into day eight or nine, while others notice effects declining by day six
Semaglutide, an injectable antidiabetic medication, is primarily prescribed for treating type 2 diabetes
Cardiac comorbidities included in addition to coronary heart disease also hypertension and atrial fibrillation (Fig
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus